Xue Liu

1.7k citations
38 papers · 1.2k indexed · h-index 20
Topics
Inflammasome and immune disorders (6 papers)Cancer-related molecular mechanisms research (4 papers)Neuroinflammation and Neurodegeneration Mechanisms (3 papers)

In The Last Decade

Xue Liu

37 papers receiving 1.2k citations

Peers

Xue Liu
Comparison fields: 5 of 96
  • Molecular Biology 820
  • Immunology 331
  • Cancer Research 268
  • Oncology 111
  • Neurology 102
Replace Fei He with:
Fei He China
Jacques Behmoaras United Kingdom
Kyle Jablonski United States
Raquel Domingo-Fernandéz Ireland
Samuel García Netherlands
Sho Morioka United States
Dennis H. M. Kusters Netherlands
Danilo Cucchi Italy
Hedwich F. Kuipers United States
Samah Shah United States
Xue Liu relative to Fei He China Fei He's profile →
Citations per field
00.5×1.7×
Fei He · 1×
Citations per year

Countries citing papers authored by Xue Liu

Since Specialization
Citations

This map shows the geographic impact of Xue Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Liu more than expected).

Fields of papers citing papers by Xue Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Liu. The network helps show where Xue Liu may publish in the future.

Co-authorship network of co-authors of Xue Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Liu. A scholar is included among the top collaborators of Xue Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Liu. Xue Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 17
3 2
4 7
5 0
6 28
7 9
8 25
9 7
10 33
11 126
12 67
13 39
14 53
15 15
16 28
17 12
18 52
19 21
20
Expression of Smac/Diablo in neonatal rats with hypoxic-ischemic brain damage and protective mechanism of shenfu injection
1

About Xue Liu

Xue Liu is a scholar working on Developmental Neuroscience, Immunology and Cancer Research, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (6 papers), Cancer-related molecular mechanisms research (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). The work is most often cited by research in Cancer Research (268 citations), Biological Psychiatry (40 citations) and Immunology (331 citations). Xue Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Chunmei Ma, Bingwei Wang, Shuo Yang, Yuqing Wu, Sheng Li, Chunyan Wu, Paul N. Moynagh, Gang Hu, Jiawei Zhou and Yingchao Hu. Their work appears in journals such as Advanced Materials, The Journal of Experimental Medicine and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026